Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Hägglund
H
H
Division of Clinical Immunology, Huddinge Hospital, Sweden.
Boström
L
L
Ringdén
O
O
Nilsson
B
B
Remberger
M
M
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000704:Analysis of Variance; D000741:Anemia, Aplastic / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000150:complications; D006650:Histocompatibility Testing; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000628:therapy; D008212:Lymphocyte Depletion; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D015999:Multivariate Analysis; D012044:Regression Analysis; D012307:Risk Factors; D014184:Transplantation, Homologous
D016572:Cyclosporine; D008727:Methotrexate